Spyre Therapeutics, Inc. (SYRE)

NASDAQ: SYRE · Real-Time Price · USD

47.31

-0.21 (-0.44%)

At close: Mar 27, 2026, 4:00 PM EDT

47.41

+0.10 (0.21%)

After-hours: Mar 27, 2026, 5:40 PM EDT

Spyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	85.72	89.42	188.89	34.86	15.14
Short-Term Investments	670.81	513.67	150.38	20.85	77.99
Cash & Short-Term Investments	756.53	603.09	339.28	55.71	93.13
Cash Growth	25.44%	77.76%	509.00%	-40.18%	-36.33%
Accounts Receivable	-	-	-	0.38	0.82
Other Current Assets	21.25	5.39	2.25	6.17	4.95
Total Current Assets	777.78	608.47	341.53	62.26	98.89
Net Property, Plant & Equipment	-	-	-	6.65	8.36
Other Long-Term Assets	-	0.01	0.33	2.24	2.68
Total Assets	777.78	608.48	341.86	71.14	109.93
Accounts Payable	8.9	0.67	0.9	0.68	3.32
Accrued Expenses	26.95	27.71	13.11	12.84	14.03
Current Portion of Leases	-	-	-	0.63	0.44
Unearned Revenue	-	-	-	0.52	2.36
Other Current Liabilities	22.83	25.68	17.97	-	-
Total Current Liabilities	58.69	54.06	31.98	14.66	20.14
Long-Term Leases	-	-	-	4	4.61
Other Long-Term Liabilities	3.86	36.62	41.31	2.18	1.23
Total Long-Term Liabilities	3.86	36.62	41.31	6.18	5.84
Total Liabilities	62.55	90.68	73.29	20.84	25.99
Preferred Stock	155.82	155.82	184.93	-	-
Common Stock	0.02	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,686	1,334	763.19	475.97	425.77
Accumulated Other Comprehensive Income	0.87	0.18	0.3	-0.05	-0.02
Retained Earnings	-1,128	-972.43	-764.41	-425.62	-341.81
Minority Interest	-	-	84.56	-	-
Shareholders' Equity	715.24	517.8	184.02	50.31	83.94
Total Liabilities & Equity	777.78	608.48	341.86	71.14	109.93
Total Debt	0	0	0	4.63	5.04
Net Cash (Debt)	756.53	603.09	339.28	51.08	88.08
Net Cash Growth	25.44%	77.76%	564.18%	-42.01%	-37.45%
Net Cash Per Share	11.81	12.82	49.19	-	-
Book Value	715.24	517.8	184.02	50.31	83.94
Book Value Per Share	11.17	11.01	26.68	-	-
Tangible Book Value	715.24	517.8	184.02	50.31	83.94
Tangible Book Value Per Share	11.17	11.01	26.68	-	-

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q